✦ LIBER ✦

P.80 INFLIXIMAB FOR SEVERE ULCERATIVE COLITIS: SHORT-TERM AND ONE YEAR OUTCOME OF THREE DOSE REGIMEN. AN ITALIAN MULTICENTRE OPEN-LABEL STUDY

✍ Scribed by R. Monterubbianesi; M. Daperno; A. Armuzzi; L. Biancone; M. Cappello; A. Lavagna; V. Annese; A. Orlando; A. Viscido; G. Riegler; G. Meucci; C. Papi; R. Sostegni; M. Guidi; A. Gasbarrini; C. Petruzziello; S. Peralta; A. Aratari; C. Prantera; A. Kohn

Book ID: 119633789
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 59 KB
Volume: 42
Category: Article
ISSN: 1590-8658
DOI: 10.1016/s1590-8658(10)60193-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

W1257 Infliximab for Severe Ulcerative C

W1257 Infliximab for Severe Ulcerative Colitis: Short-Term and One Year Outcome of Three Dose Regimen. An Italian Multicentre Open-Label Study

✍ Monterubbianesi, Rita; Daperno, Marco; Armuzzi, Alessandro; Biancone, Livia; Cap 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 66 KB

OC3.11.5 INFLIXIMAB FOR SEVERE ULCERATIV

OC3.11.5 INFLIXIMAB FOR SEVERE ULCERATIVE COLITIS: SHORT-TERM EFFICACY OF THREE-DOSE REGIMEN AND LONG-TERM OUTCOME. AN ITALIAN MULTICENTRIC OPEN-LABEL STUDY ON BEHALF OF THE IG-IBD

✍ A. Kohn; M. Daperno; A. Armuzzi; L. Biancone; M. Cappello; A. Lavagna; V. Annese 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 74 KB

Short and Long Term Outcome of Inflixima

Short and Long Term Outcome of Infliximab Scheduled Therapy for Acute, Severe Ulcerative Colitis. A Prospective, Open Label, Single-Centre, Two-Year Study

✍ Papamichael, Konstantinos ;Archavlis, Emmanuel J. ;Smyrnidis, Alexandros ;Agalos 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 44 KB